We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Centene (CNC) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
Centene (CNC - Free Report) closed the most recent trading day at $136, moving +0.1% from the previous trading session. This move lagged the S&P 500's daily gain of 0.22%. Elsewhere, the Dow gained 0.49%, while the tech-heavy Nasdaq lost 0.15%.
Coming into today, shares of the healthcare company had lost 6.87% in the past month. In that same time, the Medical sector gained 0.16%, while the S&P 500 lost 0.57%.
Investors will be hoping for strength from CNC as it approaches its next earnings release, which is expected to be February 5, 2019. In that report, analysts expect CNC to post earnings of $1.33 per share. This would mark year-over-year growth of 37.11%. Meanwhile, our latest consensus estimate is calling for revenue of $16.35 billion, up 27.64% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $7.05 per share and revenue of $59.96 billion, which would represent changes of +40.16% and +23.93%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for CNC. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.53% lower within the past month. CNC is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, CNC currently has a Forward P/E ratio of 19.29. Its industry sports an average Forward P/E of 19.29, so we one might conclude that CNC is trading at a no noticeable deviation comparatively.
Meanwhile, CNC's PEG ratio is currently 1.28. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs was holding an average PEG ratio of 1.43 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 73, which puts it in the top 28% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Centene (CNC) Gains But Lags Market: What You Should Know
Centene (CNC - Free Report) closed the most recent trading day at $136, moving +0.1% from the previous trading session. This move lagged the S&P 500's daily gain of 0.22%. Elsewhere, the Dow gained 0.49%, while the tech-heavy Nasdaq lost 0.15%.
Coming into today, shares of the healthcare company had lost 6.87% in the past month. In that same time, the Medical sector gained 0.16%, while the S&P 500 lost 0.57%.
Investors will be hoping for strength from CNC as it approaches its next earnings release, which is expected to be February 5, 2019. In that report, analysts expect CNC to post earnings of $1.33 per share. This would mark year-over-year growth of 37.11%. Meanwhile, our latest consensus estimate is calling for revenue of $16.35 billion, up 27.64% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $7.05 per share and revenue of $59.96 billion, which would represent changes of +40.16% and +23.93%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for CNC. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.53% lower within the past month. CNC is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, CNC currently has a Forward P/E ratio of 19.29. Its industry sports an average Forward P/E of 19.29, so we one might conclude that CNC is trading at a no noticeable deviation comparatively.
Meanwhile, CNC's PEG ratio is currently 1.28. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs was holding an average PEG ratio of 1.43 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 73, which puts it in the top 28% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.